Avid Bioservices Inc (CDMO)

[jakedogman1]

They way I see it is the stock price won't move until we get confirmation on clinical data and we get institutional coverage as in buy the sucker cause it's good. Saying that, we have a hurdle in that institutions will not buy a $1.00 stock. Will they buy a $3 or $5 stock? Possibly. But to get to $3 or $5, the market cap needs to be $675 mil to $1.1 bil. See the problem? The company will not get there without institutional ownership and institutional ownership will not happen until the company gets in that stock price range (which probably requires a reverse split). And the further the company gets from getting there, the harder it is to move forward. If the company gets delisted, I think a shareholder revolt and forced sale is a real possibility.